Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperbaric Oxygenation | 30 | 2016 | 165 | 4.510 |
Why?
|
Brain Ischemia | 38 | 2023 | 3049 | 3.410 |
Why?
|
Stroke | 58 | 2024 | 9758 | 2.540 |
Why?
|
Cerebral Infarction | 18 | 2024 | 983 | 2.080 |
Why?
|
Ischemic Attack, Transient | 18 | 2024 | 882 | 2.000 |
Why?
|
Brain Infarction | 9 | 2023 | 290 | 1.910 |
Why?
|
Diabetic Foot | 10 | 2018 | 380 | 1.850 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | 2024 | 34 | 1.790 |
Why?
|
Vagus Nerve Stimulation | 6 | 2022 | 228 | 1.610 |
Why?
|
Vitamin A | 3 | 2022 | 613 | 1.480 |
Why?
|
Foot Ulcer | 4 | 2015 | 63 | 1.450 |
Why?
|
Hyaluronoglucosaminidase | 3 | 2024 | 136 | 1.380 |
Why?
|
Leukoaraiosis | 4 | 2013 | 116 | 1.330 |
Why?
|
Diffusion Magnetic Resonance Imaging | 19 | 2019 | 2791 | 1.120 |
Why?
|
Rats, Wistar | 8 | 2024 | 1848 | 1.020 |
Why?
|
Valproic Acid | 2 | 2024 | 443 | 0.980 |
Why?
|
Microdialysis | 1 | 2024 | 161 | 0.950 |
Why?
|
Infarction, Middle Cerebral Artery | 9 | 2012 | 485 | 0.870 |
Why?
|
Diterpenes | 2 | 2022 | 171 | 0.860 |
Why?
|
Thalamus | 3 | 2024 | 1047 | 0.770 |
Why?
|
Serotonin | 1 | 2024 | 1041 | 0.680 |
Why?
|
Long QT Syndrome | 1 | 2023 | 467 | 0.640 |
Why?
|
Oxidative Stress | 11 | 2016 | 3113 | 0.640 |
Why?
|
Glutamic Acid | 1 | 2024 | 1176 | 0.640 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2024 | 1141 | 0.610 |
Why?
|
Glycogen Phosphorylase | 1 | 2017 | 15 | 0.600 |
Why?
|
Cerebral Arterial Diseases | 2 | 2017 | 82 | 0.590 |
Why?
|
Brain | 31 | 2020 | 27121 | 0.580 |
Why?
|
Oxygen | 6 | 2015 | 4227 | 0.580 |
Why?
|
Carbon Monoxide Poisoning | 3 | 2012 | 65 | 0.540 |
Why?
|
Rats | 22 | 2024 | 23741 | 0.530 |
Why?
|
Atmospheric Pressure | 2 | 2014 | 46 | 0.490 |
Why?
|
Troponin T | 4 | 2023 | 780 | 0.490 |
Why?
|
Synostosis | 1 | 2014 | 43 | 0.470 |
Why?
|
Male | 120 | 2024 | 360846 | 0.470 |
Why?
|
Cerebral Hemorrhage | 10 | 2024 | 2656 | 0.460 |
Why?
|
Glutathione Peroxidase | 7 | 2012 | 258 | 0.460 |
Why?
|
Aged, 80 and over | 44 | 2024 | 58984 | 0.460 |
Why?
|
Blood Preservation | 1 | 2015 | 169 | 0.450 |
Why?
|
Ear, External | 1 | 2014 | 165 | 0.450 |
Why?
|
Olfactory Perception | 1 | 2014 | 65 | 0.450 |
Why?
|
Aged | 79 | 2024 | 169310 | 0.440 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 170 | 0.440 |
Why?
|
Toes | 1 | 2014 | 209 | 0.440 |
Why?
|
Pterygopalatine Fossa | 1 | 2012 | 8 | 0.430 |
Why?
|
Cerebral Cortex | 7 | 2009 | 5779 | 0.420 |
Why?
|
Sodium Hydroxide | 1 | 2012 | 37 | 0.420 |
Why?
|
Ganglia, Autonomic | 1 | 2012 | 43 | 0.420 |
Why?
|
Intracranial Hemorrhages | 5 | 2024 | 822 | 0.420 |
Why?
|
Recurrence | 6 | 2021 | 8466 | 0.420 |
Why?
|
Cerebrovascular Circulation | 9 | 2020 | 2727 | 0.410 |
Why?
|
Erythrocytes | 3 | 2015 | 2413 | 0.410 |
Why?
|
Lipid Peroxidation | 6 | 2011 | 271 | 0.410 |
Why?
|
Daptomycin | 1 | 2012 | 71 | 0.400 |
Why?
|
Hearing Loss, Sudden | 1 | 2012 | 45 | 0.400 |
Why?
|
Pets | 1 | 2012 | 46 | 0.400 |
Why?
|
Smell | 1 | 2014 | 259 | 0.390 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2014 | 156 | 0.390 |
Why?
|
Debridement | 1 | 2014 | 493 | 0.390 |
Why?
|
Birds | 1 | 2012 | 168 | 0.390 |
Why?
|
Middle Aged | 79 | 2024 | 220921 | 0.390 |
Why?
|
Magnetic Resonance Imaging | 35 | 2024 | 36426 | 0.380 |
Why?
|
Soft Tissue Injuries | 1 | 2013 | 172 | 0.380 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 463 | 0.380 |
Why?
|
Burns, Chemical | 1 | 2012 | 123 | 0.380 |
Why?
|
Cerebrum | 1 | 2012 | 132 | 0.380 |
Why?
|
Vitamins | 1 | 2020 | 1635 | 0.380 |
Why?
|
Neuroprotective Agents | 4 | 2019 | 957 | 0.360 |
Why?
|
Female | 101 | 2024 | 392705 | 0.360 |
Why?
|
Superoxide Dismutase | 6 | 2012 | 594 | 0.360 |
Why?
|
Diagnostic Self Evaluation | 1 | 2012 | 224 | 0.350 |
Why?
|
Self Care | 1 | 2015 | 796 | 0.350 |
Why?
|
Digestive System Abnormalities | 1 | 2010 | 49 | 0.340 |
Why?
|
Pyridoxine | 1 | 2010 | 108 | 0.340 |
Why?
|
Humans | 140 | 2024 | 761596 | 0.340 |
Why?
|
Puerperal Disorders | 1 | 2012 | 300 | 0.330 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.330 |
Why?
|
Urethral Stricture | 1 | 2009 | 50 | 0.330 |
Why?
|
Syncope | 1 | 2012 | 427 | 0.330 |
Why?
|
Magnetic Resonance Angiography | 3 | 2011 | 1432 | 0.320 |
Why?
|
Cerebrovascular Disorders | 4 | 1999 | 1474 | 0.320 |
Why?
|
Radial Nerve | 1 | 2008 | 42 | 0.320 |
Why?
|
Anti-Bacterial Agents | 6 | 2018 | 7406 | 0.310 |
Why?
|
Predictive Value of Tests | 16 | 2020 | 15266 | 0.300 |
Why?
|
Hippocampus | 2 | 2020 | 3766 | 0.290 |
Why?
|
Craniofacial Abnormalities | 1 | 2010 | 319 | 0.280 |
Why?
|
Neutropenia | 1 | 2012 | 885 | 0.280 |
Why?
|
Vision Disorders | 2 | 2012 | 1088 | 0.280 |
Why?
|
International Normalized Ratio | 1 | 2008 | 382 | 0.270 |
Why?
|
Sympathetic Nervous System | 2 | 2008 | 518 | 0.270 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1173 | 0.270 |
Why?
|
Atherosclerosis | 2 | 2017 | 3407 | 0.270 |
Why?
|
Neurons | 4 | 2024 | 9463 | 0.260 |
Why?
|
Ticlopidine | 1 | 2011 | 730 | 0.260 |
Why?
|
Burns | 2 | 2014 | 1882 | 0.260 |
Why?
|
Radiation Injuries | 1 | 2013 | 1189 | 0.260 |
Why?
|
Wound Healing | 3 | 2016 | 2805 | 0.250 |
Why?
|
Humeral Fractures | 1 | 2008 | 282 | 0.250 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2007 | 710 | 0.250 |
Why?
|
Vasoactive Intestinal Peptide | 2 | 2018 | 180 | 0.250 |
Why?
|
Fibrinolytic Agents | 5 | 2023 | 2084 | 0.250 |
Why?
|
Solitary Nucleus | 2 | 2015 | 54 | 0.240 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 5127 | 0.240 |
Why?
|
Cell Count | 3 | 2024 | 1835 | 0.240 |
Why?
|
Drug Resistance | 1 | 2011 | 1596 | 0.240 |
Why?
|
Turkey | 6 | 2016 | 254 | 0.240 |
Why?
|
Infusions, Subcutaneous | 1 | 2024 | 43 | 0.240 |
Why?
|
Thiobarbituric Acid Reactive Substances | 4 | 2007 | 45 | 0.240 |
Why?
|
Fever | 1 | 2012 | 1618 | 0.240 |
Why?
|
Severity of Illness Index | 12 | 2024 | 15843 | 0.240 |
Why?
|
Treatment Outcome | 23 | 2024 | 64685 | 0.230 |
Why?
|
Thrombocytopenia | 1 | 2012 | 1182 | 0.230 |
Why?
|
Device Removal | 1 | 2009 | 630 | 0.230 |
Why?
|
Cyclosporine | 1 | 2007 | 778 | 0.230 |
Why?
|
Trachea | 2 | 2015 | 1089 | 0.230 |
Why?
|
Carotid Stenosis | 3 | 2021 | 860 | 0.230 |
Why?
|
Functional Laterality | 4 | 2012 | 2257 | 0.230 |
Why?
|
Gram-Positive Bacteria | 2 | 2016 | 177 | 0.220 |
Why?
|
Adult | 50 | 2024 | 221210 | 0.220 |
Why?
|
Heart Rate | 4 | 2015 | 4195 | 0.220 |
Why?
|
Risk Factors | 27 | 2024 | 74213 | 0.220 |
Why?
|
Injections, Subcutaneous | 1 | 2024 | 681 | 0.210 |
Why?
|
Gram-Negative Bacteria | 2 | 2016 | 272 | 0.210 |
Why?
|
Angioplasty | 1 | 2005 | 355 | 0.210 |
Why?
|
Piperacillin | 2 | 2012 | 37 | 0.210 |
Why?
|
Osteoporosis | 1 | 2012 | 1606 | 0.210 |
Why?
|
Thrombolytic Therapy | 4 | 2015 | 2064 | 0.210 |
Why?
|
Penicillanic Acid | 2 | 2012 | 42 | 0.200 |
Why?
|
Osteomyelitis | 3 | 2018 | 407 | 0.200 |
Why?
|
Hyperhomocysteinemia | 1 | 2003 | 118 | 0.200 |
Why?
|
Animals | 27 | 2024 | 168475 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 2015 | 586 | 0.200 |
Why?
|
Barotrauma | 3 | 2008 | 39 | 0.200 |
Why?
|
Infarction, Anterior Cerebral Artery | 1 | 2002 | 12 | 0.200 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2002 | 45 | 0.200 |
Why?
|
Anatomy | 1 | 2003 | 126 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2014 | 12149 | 0.190 |
Why?
|
Cardiomyopathies | 2 | 2020 | 1964 | 0.190 |
Why?
|
Tracheal Stenosis | 1 | 2003 | 228 | 0.190 |
Why?
|
Rats, Sprague-Dawley | 10 | 2024 | 8181 | 0.190 |
Why?
|
Carotid Arteries | 1 | 2005 | 941 | 0.190 |
Why?
|
Cerebral Arteries | 3 | 2008 | 490 | 0.190 |
Why?
|
Motor Activity | 3 | 2014 | 2715 | 0.190 |
Why?
|
Myocardium | 2 | 2006 | 4725 | 0.180 |
Why?
|
Aging | 3 | 2011 | 8710 | 0.180 |
Why?
|
Risk Assessment | 13 | 2021 | 23996 | 0.180 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 629 | 0.180 |
Why?
|
Hand | 2 | 2012 | 903 | 0.180 |
Why?
|
Disease Progression | 9 | 2011 | 13510 | 0.170 |
Why?
|
Endarterectomy, Carotid | 1 | 2005 | 555 | 0.170 |
Why?
|
Warfarin | 1 | 2008 | 1483 | 0.170 |
Why?
|
Pregnancy | 6 | 2024 | 29890 | 0.170 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2015 | 2751 | 0.170 |
Why?
|
Reproducibility of Results | 10 | 2017 | 20100 | 0.170 |
Why?
|
Cartilage | 1 | 2003 | 806 | 0.170 |
Why?
|
Creatine Kinase | 1 | 2002 | 685 | 0.170 |
Why?
|
Causality | 3 | 2011 | 1242 | 0.170 |
Why?
|
Kidney Diseases | 2 | 2009 | 2091 | 0.170 |
Why?
|
Retrospective Studies | 24 | 2021 | 80647 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 11 | 2019 | 20568 | 0.160 |
Why?
|
Blood Pressure | 6 | 2015 | 8481 | 0.160 |
Why?
|
Aspirin | 1 | 2011 | 3133 | 0.160 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 344 | 0.160 |
Why?
|
Behavior, Animal | 3 | 2024 | 1878 | 0.160 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18255 | 0.160 |
Why?
|
Cerebral Angiography | 4 | 2010 | 1281 | 0.160 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2023 | 664 | 0.160 |
Why?
|
In Situ Nick-End Labeling | 1 | 2020 | 613 | 0.160 |
Why?
|
Risk | 5 | 2021 | 9610 | 0.160 |
Why?
|
Atrial Function, Left | 1 | 2020 | 185 | 0.160 |
Why?
|
Heart Septal Defects, Atrial | 2 | 1998 | 451 | 0.160 |
Why?
|
Regression Analysis | 3 | 2017 | 6345 | 0.150 |
Why?
|
Autistic Disorder | 2 | 2024 | 1220 | 0.150 |
Why?
|
Hemiplegia | 1 | 1998 | 136 | 0.150 |
Why?
|
Statistics, Nonparametric | 4 | 2017 | 2850 | 0.150 |
Why?
|
Prognosis | 11 | 2020 | 29629 | 0.150 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2190 | 0.150 |
Why?
|
Phenotype | 6 | 2014 | 16592 | 0.150 |
Why?
|
Heart Atria | 2 | 2020 | 1345 | 0.150 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 3246 | 0.140 |
Why?
|
Observer Variation | 4 | 2008 | 2606 | 0.140 |
Why?
|
Necrosis | 3 | 2013 | 1611 | 0.140 |
Why?
|
Isoenzymes | 1 | 2002 | 1687 | 0.140 |
Why?
|
Melanoma | 1 | 2015 | 5709 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 592 | 0.140 |
Why?
|
ROC Curve | 2 | 2017 | 3578 | 0.140 |
Why?
|
Drug Resistance, Multiple | 1 | 2018 | 255 | 0.140 |
Why?
|
Random Allocation | 4 | 2016 | 2395 | 0.140 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14665 | 0.130 |
Why?
|
Amnesia | 1 | 1998 | 257 | 0.130 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5821 | 0.130 |
Why?
|
Pregnenediones | 1 | 2015 | 29 | 0.130 |
Why?
|
Area Under Curve | 2 | 2017 | 1638 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2009 | 705 | 0.130 |
Why?
|
Splanchnic Circulation | 1 | 2016 | 119 | 0.130 |
Why?
|
Immunologic Factors | 1 | 2024 | 1590 | 0.120 |
Why?
|
Diving | 2 | 2011 | 43 | 0.120 |
Why?
|
Algorithms | 4 | 2009 | 14033 | 0.120 |
Why?
|
Early Diagnosis | 2 | 2011 | 1186 | 0.120 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2019 | 3359 | 0.120 |
Why?
|
Citrates | 1 | 2015 | 134 | 0.120 |
Why?
|
Prospective Studies | 16 | 2024 | 54423 | 0.120 |
Why?
|
Double-Blind Method | 4 | 2024 | 12341 | 0.120 |
Why?
|
Acute Disease | 7 | 2010 | 7237 | 0.120 |
Why?
|
Blood Transfusion, Autologous | 1 | 2015 | 130 | 0.120 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39106 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1039 | 0.120 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2020 | 607 | 0.120 |
Why?
|
Awareness | 1 | 1998 | 648 | 0.110 |
Why?
|
Erythrocyte Indices | 1 | 2015 | 144 | 0.110 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2015 | 144 | 0.110 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4176 | 0.110 |
Why?
|
Cohort Studies | 9 | 2024 | 41495 | 0.110 |
Why?
|
Time Factors | 17 | 2019 | 39969 | 0.110 |
Why?
|
Wound Infection | 1 | 2016 | 246 | 0.110 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3688 | 0.110 |
Why?
|
Lung | 3 | 2011 | 10002 | 0.110 |
Why?
|
Sex Factors | 4 | 2024 | 10554 | 0.110 |
Why?
|
Electrodes, Implanted | 2 | 2015 | 840 | 0.110 |
Why?
|
Humidity | 1 | 2014 | 205 | 0.110 |
Why?
|
Vagus Nerve | 1 | 2015 | 458 | 0.110 |
Why?
|
Infarction | 3 | 2022 | 248 | 0.100 |
Why?
|
Sensory Thresholds | 1 | 2014 | 377 | 0.100 |
Why?
|
Single-Blind Method | 3 | 2010 | 1574 | 0.100 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2009 | 952 | 0.100 |
Why?
|
Cyanosis | 1 | 2013 | 82 | 0.100 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4544 | 0.100 |
Why?
|
Heart Diseases | 2 | 2003 | 2781 | 0.100 |
Why?
|
Locus Coeruleus | 1 | 2014 | 230 | 0.100 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2014 | 219 | 0.100 |
Why?
|
Databases, Nucleic Acid | 1 | 2013 | 205 | 0.100 |
Why?
|
Ulcer | 1 | 2013 | 204 | 0.100 |
Why?
|
Psychomotor Disorders | 1 | 2012 | 149 | 0.100 |
Why?
|
Anticoagulants | 3 | 2023 | 4812 | 0.100 |
Why?
|
Decompression Sickness | 1 | 2011 | 16 | 0.100 |
Why?
|
Decompression | 1 | 2011 | 36 | 0.100 |
Why?
|
Foot Injuries | 1 | 2013 | 149 | 0.100 |
Why?
|
Heparin | 1 | 2019 | 1634 | 0.100 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2013 | 238 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2013 | 9001 | 0.100 |
Why?
|
Secondary Prevention | 2 | 2024 | 1475 | 0.090 |
Why?
|
Hypertension | 5 | 2021 | 8540 | 0.090 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2016 | 587 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 540 | 0.090 |
Why?
|
Ischemia | 2 | 2020 | 1884 | 0.090 |
Why?
|
Kidney | 1 | 2007 | 7048 | 0.090 |
Why?
|
Internet | 3 | 2013 | 3093 | 0.090 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2013 | 215 | 0.090 |
Why?
|
Telangiectasis | 1 | 2011 | 78 | 0.090 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2024 | 0.090 |
Why?
|
Neurologic Examination | 2 | 2008 | 916 | 0.090 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2013 | 343 | 0.090 |
Why?
|
Bacteriological Techniques | 1 | 2012 | 275 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 1 | 2016 | 1164 | 0.090 |
Why?
|
Femur Head | 1 | 2012 | 297 | 0.090 |
Why?
|
Cryopreservation | 1 | 2015 | 728 | 0.090 |
Why?
|
Brain Stem Infarctions | 2 | 2001 | 31 | 0.090 |
Why?
|
Confusion | 1 | 2012 | 278 | 0.090 |
Why?
|
Comorbidity | 4 | 2009 | 10508 | 0.090 |
Why?
|
Ablation Techniques | 1 | 2012 | 248 | 0.090 |
Why?
|
Diabetic Neuropathies | 1 | 2013 | 405 | 0.080 |
Why?
|
Intracranial Arterial Diseases | 1 | 2009 | 22 | 0.080 |
Why?
|
Teratogens | 1 | 2010 | 117 | 0.080 |
Why?
|
Diagnosis, Differential | 7 | 2011 | 12973 | 0.080 |
Why?
|
Brain Diseases | 1 | 1998 | 1546 | 0.080 |
Why?
|
Electrocardiography | 3 | 2011 | 6377 | 0.080 |
Why?
|
Incidence | 8 | 2018 | 21355 | 0.080 |
Why?
|
Young Adult | 7 | 2024 | 59260 | 0.080 |
Why?
|
Parkinsonian Disorders | 1 | 2012 | 284 | 0.080 |
Why?
|
Platelet Function Tests | 1 | 2011 | 271 | 0.080 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2011 | 361 | 0.080 |
Why?
|
Aphasia | 1 | 2010 | 192 | 0.080 |
Why?
|
Embolism | 1 | 2012 | 399 | 0.080 |
Why?
|
Paranasal Sinuses | 1 | 2011 | 265 | 0.080 |
Why?
|
Electroencephalography | 4 | 2005 | 6237 | 0.080 |
Why?
|
Thrombosis | 1 | 2003 | 2942 | 0.080 |
Why?
|
Otoscopy | 1 | 2008 | 40 | 0.080 |
Why?
|
Vomiting | 1 | 2012 | 651 | 0.080 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1745 | 0.080 |
Why?
|
Skin | 2 | 2012 | 4484 | 0.080 |
Why?
|
Nasal Mucosa | 1 | 2011 | 416 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9280 | 0.080 |
Why?
|
Adolescent | 12 | 2024 | 88326 | 0.080 |
Why?
|
Echocardiography, Transesophageal | 2 | 2005 | 1086 | 0.080 |
Why?
|
Ozone | 1 | 2011 | 483 | 0.080 |
Why?
|
Tandem Repeat Sequences | 1 | 2009 | 180 | 0.080 |
Why?
|
Pressure | 2 | 2016 | 1154 | 0.070 |
Why?
|
Firearms | 1 | 2015 | 626 | 0.070 |
Why?
|
Neuroradiography | 1 | 2008 | 71 | 0.070 |
Why?
|
Attention | 1 | 1998 | 2396 | 0.070 |
Why?
|
Data Collection | 2 | 2014 | 3322 | 0.070 |
Why?
|
Colon | 1 | 2016 | 1792 | 0.070 |
Why?
|
Eye Abnormalities | 1 | 2010 | 242 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1422 | 0.070 |
Why?
|
Remission Induction | 1 | 2013 | 2397 | 0.070 |
Why?
|
Iodine | 1 | 2009 | 288 | 0.070 |
Why?
|
Temperature | 1 | 2014 | 2226 | 0.070 |
Why?
|
Specimen Handling | 1 | 2012 | 702 | 0.070 |
Why?
|
Brain Mapping | 3 | 2012 | 6635 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12463 | 0.070 |
Why?
|
Cerebellum | 1 | 2014 | 1501 | 0.070 |
Why?
|
Vasodilation | 2 | 2009 | 962 | 0.070 |
Why?
|
Intracranial Embolism | 1 | 2008 | 189 | 0.070 |
Why?
|
Hot Temperature | 1 | 2013 | 1440 | 0.070 |
Why?
|
Liver | 1 | 2022 | 7528 | 0.070 |
Why?
|
Anatomy, Artistic | 1 | 2006 | 51 | 0.070 |
Why?
|
Pravastatin | 1 | 2008 | 392 | 0.070 |
Why?
|
Brachial Artery | 1 | 2008 | 366 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 1809 | 0.060 |
Why?
|
Medical Illustration | 1 | 2006 | 135 | 0.060 |
Why?
|
Corpus Striatum | 1 | 2012 | 1235 | 0.060 |
Why?
|
Malondialdehyde | 3 | 2012 | 112 | 0.060 |
Why?
|
Sex Distribution | 1 | 2011 | 2280 | 0.060 |
Why?
|
Emergencies | 1 | 2012 | 1217 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4853 | 0.060 |
Why?
|
Organ Transplantation | 1 | 2015 | 1157 | 0.060 |
Why?
|
Military Personnel | 2 | 2005 | 1246 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6228 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2735 | 0.060 |
Why?
|
Platelet Aggregation | 1 | 2008 | 771 | 0.060 |
Why?
|
Mastoid | 1 | 2005 | 100 | 0.060 |
Why?
|
Age Distribution | 1 | 2011 | 2879 | 0.060 |
Why?
|
Air | 1 | 2005 | 187 | 0.060 |
Why?
|
Free Radical Scavengers | 1 | 2005 | 211 | 0.060 |
Why?
|
Thromboangiitis Obliterans | 1 | 2004 | 8 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 679 | 0.060 |
Why?
|
High Pressure Neurological Syndrome | 1 | 2004 | 3 | 0.060 |
Why?
|
Cadaver | 1 | 2008 | 1358 | 0.060 |
Why?
|
Mood Disorders | 1 | 2011 | 1127 | 0.060 |
Why?
|
Byzantium | 1 | 2003 | 1 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2612 | 0.060 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 654 | 0.060 |
Why?
|
Europe | 3 | 2019 | 3420 | 0.060 |
Why?
|
History, Medieval | 1 | 2003 | 62 | 0.060 |
Why?
|
Laparoscopy | 1 | 2016 | 2036 | 0.060 |
Why?
|
Chlorates | 1 | 2003 | 12 | 0.060 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2005 | 281 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4768 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2007 | 1157 | 0.060 |
Why?
|
Genome-Wide Association Study | 4 | 2019 | 12690 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9490 | 0.060 |
Why?
|
Spectrum Analysis | 1 | 2005 | 453 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2010 | 1192 | 0.060 |
Why?
|
Embolism, Air | 1 | 2004 | 110 | 0.050 |
Why?
|
Neuronal Plasticity | 1 | 2012 | 1436 | 0.050 |
Why?
|
Austria | 1 | 2003 | 207 | 0.050 |
Why?
|
Genotype | 2 | 2019 | 12990 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6484 | 0.050 |
Why?
|
Microcirculation | 1 | 2008 | 1272 | 0.050 |
Why?
|
Migraine Disorders | 1 | 2015 | 1703 | 0.050 |
Why?
|
United States | 7 | 2016 | 72340 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2019 | 22176 | 0.050 |
Why?
|
Glucose | 1 | 2015 | 4347 | 0.050 |
Why?
|
Wakefulness | 1 | 2010 | 1265 | 0.050 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2004 | 121 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Drug Synergism | 1 | 2007 | 1757 | 0.050 |
Why?
|
Fetus | 1 | 2010 | 1863 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
DNA Damage | 1 | 2012 | 2449 | 0.050 |
Why?
|
Thalamic Diseases | 1 | 2001 | 15 | 0.050 |
Why?
|
Suicide, Attempted | 1 | 2011 | 1402 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2518 | 0.050 |
Why?
|
Reactive Oxygen Species | 2 | 2007 | 2139 | 0.050 |
Why?
|
Atrial Appendage | 1 | 2005 | 283 | 0.050 |
Why?
|
Myoglobin | 1 | 2002 | 159 | 0.050 |
Why?
|
Medical Errors | 1 | 2010 | 1263 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2008 | 1866 | 0.050 |
Why?
|
Nurses | 1 | 2011 | 2478 | 0.050 |
Why?
|
Retina | 1 | 2012 | 2659 | 0.050 |
Why?
|
Creatine Kinase, MB Form | 1 | 2002 | 202 | 0.050 |
Why?
|
Arteries | 1 | 2006 | 1123 | 0.050 |
Why?
|
History, 19th Century | 1 | 2003 | 720 | 0.050 |
Why?
|
Syndrome | 2 | 2005 | 3267 | 0.050 |
Why?
|
Patient Admission | 1 | 2008 | 1367 | 0.050 |
Why?
|
Cesarean Section | 1 | 2010 | 1398 | 0.050 |
Why?
|
Immunoglobulins | 1 | 2024 | 852 | 0.050 |
Why?
|
Survival Analysis | 1 | 2013 | 10090 | 0.050 |
Why?
|
Dominance, Cerebral | 2 | 2001 | 623 | 0.050 |
Why?
|
Echo-Planar Imaging | 1 | 2005 | 663 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11076 | 0.050 |
Why?
|
Parietal Lobe | 1 | 2006 | 852 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2011 | 2400 | 0.040 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2007 | 781 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2010 | 5841 | 0.040 |
Why?
|
Registries | 1 | 2016 | 8225 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2113 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2011 | 2639 | 0.040 |
Why?
|
Blood Glucose | 1 | 2015 | 6391 | 0.040 |
Why?
|
Melatonin | 1 | 2005 | 669 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2021 | 130 | 0.040 |
Why?
|
Homocysteine | 1 | 2003 | 638 | 0.040 |
Why?
|
Age Factors | 3 | 2015 | 18399 | 0.040 |
Why?
|
Graft Survival | 2 | 2015 | 3820 | 0.040 |
Why?
|
Fibromyalgia | 1 | 2004 | 405 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2136 | 0.040 |
Why?
|
Ataxia | 1 | 2001 | 306 | 0.040 |
Why?
|
Genetic Loci | 2 | 2019 | 2632 | 0.040 |
Why?
|
Prevalence | 3 | 2014 | 15733 | 0.040 |
Why?
|
Recovery of Function | 3 | 2015 | 2979 | 0.040 |
Why?
|
Staphylococcus aureus | 2 | 2018 | 1457 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7213 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2548 | 0.040 |
Why?
|
Parents | 1 | 2012 | 3563 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15936 | 0.040 |
Why?
|
Disaster Planning | 1 | 2004 | 557 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5872 | 0.040 |
Why?
|
Social Behavior | 1 | 2024 | 1135 | 0.040 |
Why?
|
Blood Platelets | 1 | 2008 | 2479 | 0.040 |
Why?
|
Sensation Disorders | 1 | 1998 | 160 | 0.040 |
Why?
|
Rabbits | 1 | 2003 | 4772 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2018 | 8601 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2021 | 633 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2008 | 1923 | 0.030 |
Why?
|
Molecular Weight | 1 | 1999 | 2186 | 0.030 |
Why?
|
Hospitals | 1 | 2010 | 3883 | 0.030 |
Why?
|
Hydroxyproline | 1 | 2016 | 110 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2021 | 567 | 0.030 |
Why?
|
Klebsiella pneumoniae | 1 | 2018 | 250 | 0.030 |
Why?
|
Hearing Loss, Bilateral | 1 | 2015 | 53 | 0.030 |
Why?
|
Hearing Loss, Unilateral | 1 | 2015 | 25 | 0.030 |
Why?
|
Hospitals, University | 2 | 2010 | 564 | 0.030 |
Why?
|
Software | 1 | 2009 | 4434 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1998 | 1122 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2021 | 909 | 0.030 |
Why?
|
Epilepsy, Absence | 1 | 1995 | 49 | 0.030 |
Why?
|
Computer Simulation | 1 | 2008 | 6241 | 0.030 |
Why?
|
Tensile Strength | 1 | 2016 | 330 | 0.030 |
Why?
|
Cardiovascular Diseases | 3 | 2010 | 15502 | 0.030 |
Why?
|
Escherichia coli | 2 | 2018 | 4217 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2024 | 6534 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6374 | 0.030 |
Why?
|
Logistic Models | 1 | 2008 | 13255 | 0.030 |
Why?
|
Antioxidants | 2 | 2012 | 1668 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1633 | 0.030 |
Why?
|
Corpus Callosum | 1 | 1998 | 751 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 2008 | 1371 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15633 | 0.030 |
Why?
|
Neuroglia | 1 | 1999 | 956 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5079 | 0.030 |
Why?
|
Social Class | 1 | 2022 | 2004 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2018 | 1998 | 0.030 |
Why?
|
Purkinje Cells | 1 | 2014 | 226 | 0.030 |
Why?
|
Odds Ratio | 3 | 2014 | 9647 | 0.030 |
Why?
|
Comet Assay | 1 | 2012 | 75 | 0.030 |
Why?
|
DNA Breaks, Single-Stranded | 1 | 2012 | 24 | 0.030 |
Why?
|
Radiography | 3 | 2013 | 6965 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2016 | 983 | 0.030 |
Why?
|
Oxidopamine | 1 | 2012 | 172 | 0.020 |
Why?
|
Atmosphere | 1 | 2011 | 32 | 0.020 |
Why?
|
Escherichia coli Infections | 1 | 2016 | 518 | 0.020 |
Why?
|
Echocardiography | 2 | 2005 | 4989 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5247 | 0.020 |
Why?
|
Seizures | 1 | 2004 | 2957 | 0.020 |
Why?
|
Protein Carbonylation | 1 | 2011 | 28 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2330 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1003 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1742 | 0.020 |
Why?
|
Autopsy | 1 | 2014 | 1009 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2011 | 221 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1626 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 832 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2018 | 1277 | 0.020 |
Why?
|
Medical Audit | 1 | 2011 | 453 | 0.020 |
Why?
|
Housing | 1 | 2014 | 670 | 0.020 |
Why?
|
Hypertrophy | 1 | 2011 | 561 | 0.020 |
Why?
|
Dendrites | 1 | 2012 | 475 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42232 | 0.020 |
Why?
|
Hemodynamics | 1 | 2020 | 4160 | 0.020 |
Why?
|
Heme Oxygenase-1 | 1 | 2011 | 366 | 0.020 |
Why?
|
Cell Survival | 1 | 1999 | 5791 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2010 | 11461 | 0.020 |
Why?
|
Brain Damage, Chronic | 1 | 2010 | 267 | 0.020 |
Why?
|
Reperfusion | 1 | 2010 | 271 | 0.020 |
Why?
|
Bleeding Time | 1 | 2008 | 83 | 0.020 |
Why?
|
Ornithine | 1 | 2008 | 79 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 1283 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 348 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.020 |
Why?
|
Perfusion Imaging | 1 | 2010 | 196 | 0.020 |
Why?
|
Cell Division | 1 | 2016 | 4465 | 0.020 |
Why?
|
Anus Diseases | 1 | 2008 | 55 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2012 | 1085 | 0.020 |
Why?
|
Nitroglycerin | 1 | 2009 | 329 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2008 | 239 | 0.020 |
Why?
|
Vasomotor System | 1 | 2008 | 207 | 0.020 |
Why?
|
Phenylephrine | 1 | 2008 | 293 | 0.020 |
Why?
|
Arthritis | 1 | 2013 | 680 | 0.020 |
Why?
|
Oxyhemoglobins | 1 | 2008 | 211 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2013 | 1936 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2014 | 1403 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4807 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1334 | 0.020 |
Why?
|
Blood Circulation Time | 1 | 2006 | 10 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1407 | 0.020 |
Why?
|
Troponin I | 1 | 2011 | 651 | 0.020 |
Why?
|
Forearm | 1 | 2009 | 427 | 0.020 |
Why?
|
Ear, Middle | 1 | 2008 | 339 | 0.020 |
Why?
|
Introns | 1 | 2009 | 981 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2217 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3517 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 793 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1301 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4142 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2018 | 3839 | 0.020 |
Why?
|
American Heart Association | 1 | 2010 | 1039 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2005 | 413 | 0.020 |
Why?
|
Acoustic Impedance Tests | 1 | 2005 | 110 | 0.020 |
Why?
|
Hearing Disorders | 1 | 2005 | 126 | 0.020 |
Why?
|
Internationality | 1 | 2010 | 1001 | 0.020 |
Why?
|
Arginine | 1 | 2008 | 934 | 0.010 |
Why?
|
Submarine Medicine | 1 | 2004 | 4 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3801 | 0.010 |
Why?
|
Tinnitus | 1 | 2007 | 196 | 0.010 |
Why?
|
Abscess | 1 | 2008 | 606 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3810 | 0.010 |
Why?
|
Pain Measurement | 2 | 2004 | 3551 | 0.010 |
Why?
|
Patient Readmission | 1 | 2018 | 3271 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8527 | 0.010 |
Why?
|
Patient Discharge | 1 | 2016 | 3443 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2319 | 0.010 |
Why?
|
Databases as Topic | 1 | 2004 | 473 | 0.010 |
Why?
|
Wrist | 1 | 2004 | 227 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2713 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1023 | 0.010 |
Why?
|
Graft Rejection | 1 | 2015 | 4446 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17904 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3606 | 0.010 |
Why?
|
Hemoglobins | 1 | 2007 | 1526 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1999 | 11530 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1667 | 0.010 |
Why?
|
Portal Vein | 1 | 2004 | 431 | 0.010 |
Why?
|
Unconsciousness | 1 | 2003 | 250 | 0.010 |
Why?
|
Vision, Ocular | 1 | 2004 | 455 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 819 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2358 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6766 | 0.010 |
Why?
|
Edema | 1 | 2004 | 766 | 0.010 |
Why?
|
Pain Threshold | 1 | 2004 | 604 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 1995 | 3222 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2008 | 1555 | 0.010 |
Why?
|
Femoral Artery | 1 | 2004 | 826 | 0.010 |
Why?
|
Placebos | 1 | 2004 | 1667 | 0.010 |
Why?
|
Light | 1 | 2005 | 1353 | 0.010 |
Why?
|
Child | 4 | 2012 | 80158 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6426 | 0.010 |
Why?
|
Pain | 2 | 2004 | 5073 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8633 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7391 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4243 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2008 | 2244 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1418 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3713 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5790 | 0.010 |
Why?
|
Mice | 2 | 2018 | 81539 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 2010 | 7879 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3323 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2008 | 2882 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8833 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4431 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4920 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2884 | 0.010 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 1995 | 54 | 0.010 |
Why?
|
Crohn Disease | 1 | 2008 | 2279 | 0.010 |
Why?
|
Intestines | 1 | 2004 | 1910 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5971 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12794 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4062 | 0.010 |
Why?
|
Quality of Life | 1 | 2013 | 13367 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2000 | 12059 | 0.000 |
Why?
|
Infant | 1 | 2001 | 36193 | 0.000 |
Why?
|